Skip to main content

Table 1 Patient clinicopathological characteristics

From: Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

  n =69
Age (year)
 median 56
 range 27–89
Tumor size (mm)
  < 20 23
  ≥ 20 35
 unknown 11
Lymph node invasion
 yes 15
 no 38
 unknown 16
Ki 67 (%)
  < 20 11
  ≥ 20 52
 unknown 6
Histology
 IDC 47
 other 19
 unknown 3
Bloom
 I 6
 II 7
 III 53
 unknown 3
Molecular subtype
 ck5/6 +, ER-, Her2- 30
 ck5/6 -, ER-, Her2- 32
 unknown 7
Relapse
 yes 24
 no 45